Literature DB >> 18796496

Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.

Mary B Dail1, L Allen Shack, Janice E Chambers, Shane C Burgess.   

Abstract

A global proteomics approach was applied to model the hepatic response elicited by the toxicologically well-characterized xenobiotic phenobarbital (PB), a prototypical inducer of hepatic xenobiotic metabolizing enzymes and a well-known nongenotoxic liver carcinogen in rats. Differential detergent fractionation two-dimensional liquid chromatography electrospray ionization tandem mass spectrometry and systems biology modeling were used to identify alterations in toxicologically relevant hepatic molecular functions and biological processes in the livers of rats following a 5-day exposure to PB at 80 mg/kg/day or a vehicle control. Of the 3342 proteins identified, expression of 121 (3.6% of the total proteins) was significantly increased and 127 (3.8%) significantly decreased in the PB group compared to controls. The greatest increase was seen for cytochrome P450 (CYP) 2B2 (167-fold). All proteins with statistically significant differences from control were then analyzed using both Gene Ontology (GO) and Ingenuity Pathways Analysis (IPA, 5.0 IPA-Tox) for cellular location, function, network connectivity, and possible disease processes, especially as they relate to CYP-mediated metabolism and nongenotoxic carcinogenesis mechanisms. The GO results suggested that PB's mechanism of nongenotoxic carcinogenesis involves both increased xenobiotic metabolism, especially induction of the 2B subfamily of CYP enzymes, and increased cell cycle activity. Apoptosis, however, also increased, perhaps, as an attempt to counter the rising cancer threat. Of the IPA-mapped proteins, 41 have functions which are procarcinogenic and 14 anticarcinogenic according to the hypothesized nongenotoxic mechanism of imbalance between apoptosis and cellular proliferation. Twenty-two additional IPA nodes can be classified as procarcinogenic by the competing theory of increased metabolism resulting in the formation of reactive oxygen species. Since the systems biology modeling corresponded well to PB effects previously elucidated via more traditional methods, the global proteomic approach is proposed as a new screening methodology that can be incorporated into future toxicological studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796496      PMCID: PMC2581678          DOI: 10.1093/toxsci/kfn198

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  80 in total

1.  Probability-based validation of protein identifications using a modified SEQUEST algorithm.

Authors:  Michael J MacCoss; Christine C Wu; John R Yates
Journal:  Anal Chem       Date:  2002-11-01       Impact factor: 6.986

2.  Keratins modulate hepatic cell adhesion, size and G1/S transition.

Authors:  Luc Galarneau; Anne Loranger; Stéphane Gilbert; Normand Marceau
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

3.  Comparative proteomics analysis to annexin B1 DNA and protein vaccination in mice.

Authors:  De-An Li; Ying He; Ying-Jun Guo; Fang Wang; Shu-Xia Song; Yue Wang; Fu Yang; Xiao-Wen He; Shu-Han Sun
Journal:  Vaccine       Date:  2006-09-18       Impact factor: 3.641

4.  Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation.

Authors:  Yanbin Ji; Violeta Toader; Brian M Bennett
Journal:  Biochem Pharmacol       Date:  2002-04-15       Impact factor: 5.858

5.  Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.

Authors:  Alex Y Nie; Michael McMillian; J Brandon Parker; Angelique Leone; Stewart Bryant; Lynn Yieh; Anton Bittner; Jay Nelson; Andrew Carmen; Jackson Wan; Peter G Lord
Journal:  Mol Carcinog       Date:  2006-12       Impact factor: 4.784

6.  Prediction of compound signature using high density gene expression profiling.

Authors:  Hisham K Hamadeh; Pierre R Bushel; Supriya Jayadev; Olimpia DiSorbo; Lee Bennett; Leping Li; Raymond Tennant; Raymond Stoll; J Carl Barrett; Richard S Paules; Kerry Blanchard; Cynthia A Afshari
Journal:  Toxicol Sci       Date:  2002-06       Impact factor: 4.849

Review 7.  Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR.

Authors:  Satoru Kakizaki; Yukio Yamamoto; Akiko Ueda; Rick Moore; Tatsuya Sueyoshi; Masahiko Negishi
Journal:  Biochim Biophys Acta       Date:  2003-02-17

8.  Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.

Authors:  Laura Sonzogni; Laura Silvestri; Annalisa De Silvestri; Chiara Gritti; Luciana Foti; Claudio Zavaglia; Riccardo Bottelli; Mario U Mondelli; Emilio Civardi; Enrico M Silini
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 9.  Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis.

Authors:  Jason D Oliver; Ruth A Roberts
Journal:  Pharmacol Toxicol       Date:  2002-07

10.  AgBase: a functional genomics resource for agriculture.

Authors:  Fiona M McCarthy; Nan Wang; G Bryce Magee; Bindu Nanduri; Mark L Lawrence; Evelyn B Camon; Daniel G Barrell; David P Hill; Mary E Dolan; W Paul Williams; Dawn S Luthe; Susan M Bridges; Shane C Burgess
Journal:  BMC Genomics       Date:  2006-09-08       Impact factor: 3.969

View more
  4 in total

1.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

2.  Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR).

Authors:  J P Hernandez; L C Mota; W Huang; D D Moore; W S Baldwin
Journal:  Toxicology       Date:  2008-11-11       Impact factor: 4.221

3.  Visualizing meta-features in proteomic maps.

Authors:  Eugenia G Giannopoulou; George Lepouras; Elias S Manolakos
Journal:  BMC Bioinformatics       Date:  2011-07-28       Impact factor: 3.169

4.  GOModeler--a tool for hypothesis-testing of functional genomics datasets.

Authors:  Prashanti Manda; McKinley G Freeman; Susan M Bridges; T J Jankun-Kelly; Bindu Nanduri; Fiona M McCarthy; Shane C Burgess
Journal:  BMC Bioinformatics       Date:  2010-10-07       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.